The regulation and biological activity of interleukin 12

Leukemia and Lymphoma

Volumn 29, Issue 5-6, 1998, Pages 427-438

  Lee, Sun Min ^a   Suen, Yu ^a   Qian, John ^a   Knoppel, Eva ^a   Cairo, Mitchell S ^a  

^a CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

Author keywords

Biological activity; Interleukin 12; Regulation

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 15;

B LYMPHOCYTE; CELL MEDIATED CYTOTOXICITY; GENE EXPRESSION REGULATION; GRAFT VERSUS HOST REACTION; LEUKEMIA CELL LINE; LYMPHOKINE ACTIVATED KILLER CELL; LYMPHOMA CELL LINE; MACROPHAGE; MONOCYTE; MONONUCLEAR CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; UMBILICAL CORD BLOOD;

EID: 0031837912     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809050903     Document Type: Review

References (79)

1. Coiffier, B., Philip, T., Burnett, A. K. and Symann, M. L. (1994). Consensus conference on intensive chemotherapy plus hematopoietic stem-cell transplantation in malignancies: Lyon, France, June 4-6, 1993. J Clin Oncol, 12(1), 226.
2. Linch, D. C., Knott, L. J., Thomas, R. M., Harper, P., Goldstone, A. H., Davis, E. G. and Levinski, R. J. (1983). T-cell regeneration after allogeneic and autologous bone marrow transplantation. Br J Haematol, 53(3), 451.
3. Weite, K., Ciobanu, N., Moore, M. A., Gulati, S., O'Rielly, R. J. and Mertelsmann, R. (1984). Defective interleukin 2 production in patients after bone marrow transplantation and in vitro restoration of defective T-lymphocyte proliferation by highly purified interleukin 2. Blood, 64(2), 380.
4. Guillaume, T., Sekhavat, M., Rubinstein, D. B., Hamdan, O., Leblanc, P. and Symann, M. L. (1994). Defective cytokine production following autologous stem cell transplantation for solid tumors and hematologic malignancies regardless of bone marrow or peripheral origin and lack of evidence for a role for interleukin-10 in delayed immune reconstitution. Cancer Res, 54(14), 3800.
5. Bengtsson, T. T. H., Smedmyr, B., Festin, R., Oberg, G. and Simonsson, B. (1989). Regeneration of functional and activated NK and T sub-subset cells in the marrow and blood after autologous bone marrow transplantation: a prospective phenotypic study with 2/3-color FACS analysis. Leukemia, 3(1), 68.
6. Storek, J., Witherspoon, R. P. and Storb, R. (1995). T-cell reconstitution after bone marrow transplantation into adult patients does not resemble T-cell development in early life. Bone Marrow Transplant, 16(3), 413.
7. Rosenberg, S., Lotze, M., Muul, L., et al. (1987). A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med, 316, 889.
8. Stern, A., Podlaski, F., Hulmes, J., Pan, Y., Quinn, P., Wolitzky, A., Familletti, P., Stremlo, C., Truitt, T., Chizzonite, R. and Gately, M. (1990). Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Natl Acad Sci USA, 87, 6808.
9. Podlaski, F. J., Nanduri, V. B., Hulmes, J. D., Pan, Y.-C. E., Levin, W., Danho, W., Chizzonite, R., Gately, M. K. and Stern, A. S. (1992). Molecular characterization of interleukin 12. Arch Biochem Biophys, 294, 230.
10. Sieburth, D., Jabs, E. W., Warrington, J. A., Li, X., Lasota, J., LaForgia, S., Kelleher, K., Huebner, K. and Wasmuth, J. J. (1992). Assignment of genes encoding a unique cytokine (IL12) composed of two unrelated subunits to chromosomes 3 and 5. Genomics, 14, 59.
11. Gubler, U., Chua, A., Schoenhaut, D., Dwyer, C., McComas, W., Motyka, R., Nabavi, N., Wolitzky, A., Quinn, P., Familletti, P. and Gately, M. (1991). Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc Natl Acad Sci USA, 88, 4143.
12. Wolf, S., Temple, P., Kobayashi, M., Young, D., Dicig, M., Lowe, L., Dzialo, R., Fitz, L., Ferenz, C., Hewick, R., Kelleher, K., Herrmann, S., Clark, S., Azzoni, L., Chan, S., Trinchieri, G. and Perussia, B. (1991). Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol, 146, 3074.
13. Shaw, G. and Kamen, R. (1986). A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell, 46, 659.
14. Gearing, D. and Cosman, D. (1991). Homology of the p40 subunit of natural killer cell stimulatory factor (NKSF) with the extracellular domain of the interleukin-6 receptor. Cell, 66, 9.
15. Merberg, D., Wolf, S. and Clark, S. (1992). Sequence similarity between NKSF and the IL-6/G-CSF family. Immunol Today, 13, 77.
16. Cosman, D., Lyman, S. D., Idzerda, R. L., Beckmann, M. P., Park, L. S., Goodwin, R. G. and March, C. J. (1990). A new cytokine receptor superfamily. Trends in Biochemical Science, 15, 265.
17. Schoenhaut, D., Chua, A., Wolitzky, A., Quinn, P., Dwyer, C., McComas, W., Familletti, P., Gately, M. and Gubler, U. (1992). Cloning and expression of murine IL-12. J Immunol, 148, 3433.
18. Chizzonite, R., Truitt, T., Podlaski, F. J., Wolitzky, A. G., Quinn, P. M., Nunes, P., Stern, A. S. and Gately, M. K. (1991). IL-12: Monoclonal antibodies specific for the 40-kDa subunit block receptor binding and biologic activity on activated human lymphoblasts. J Immunol, 147, 1548.
19. Desai, B. B., Quin, P. M., Wolitzky, A. G., Mongini, P. K., Chizzonite, R. and Gately, M. K. (1992). IL-12 receptor: Distribution, regulation of receptor expression. J Immunol, 148, 3125.
20. Kobayashi, M., Fitz, L., Ryan, M., Hewick, R., Clark, S., Chan, S., Loudon, R., Sherman, F., Perussia, B. and Trinchieri, G. (1989). Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes. J Exp Med, 170, 827.
21. D'Andrea, A., Rengaraju, M., Valiante, N. M., Chehimi, J., Kubin, M., Aste, M., Chan, S. H., Kobayashi, M., Young, D., Nickbarg, E., Chizzonite, R., Wolf. S. F. and Trinchieri, G. (1992). Production of natural killer cell stimulatory factor (Interleukin 12) by peripheral blood mononuclear cells. J Exp Med, 176, 1387.
22. Kubin, M., Chow, J. M. and Trinchieri, G. (1993). Differential regulation of interleukin-12 (IL-12), tumor necrosis factor-α, and IL-1β production in human myeloid leukemia cell lines and peripheral blood mononuclear cells. Blood, 83, 1847.
23. D'Andrea, A., Aste-Amezaga, M., Valiante, N., Ma, X., Kubin, M. and Trinchieri, G. (1993). Interleukin 10 (IL-10) inhibits human lymphocyte interferon y production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med, 178, 1041.
24. Murphy, E. E., Terres, G., Macatonia, S. E., Hsieh, C., Mattson, J., Lanier, L., Wysocka, M., Trinchieri, G., Murphy, K. and O'Gana. A. (1994). B7 and IL-12 cooperate for proliferation and IFN-γ production by mouse T helper clones that are unresponsive to B7 costimulation. J Exp Med, 180, 223.
25. Wolf, S., Seiburth, D., Perussia, B., Yetz-Adalpe. J., D'Andrea, A. and Trinchieri, G. (1992). Cell Sources of natural killer cell stimulatory factor (NKSF/IL-12) transcripts and subunit expression. FASEB J, 6, 1335. (abstract)
26. Lee, S. M., Suen, Y., Chang, L., Bruner, V., Qian, J., Indes, J., Knoppel, E., van de Yen, C. and Cairo, M. S. (1996). Decreased interleukin-12 (IL-12) from activated cord versus adult peripheral blood mononuclear cells and upregulation of interferon-γ, natural killer, and lymphokine-activated killer activity by IL-12 in cord blood mononuclear cells. Blood, 88, 945.
27. Brawerman, G. (1989). Finding the right targets. Cell, 57, 9.
28. Brawerman, G. (1987). Determinants of messenger RNA stability. Cell, 48, 5.
29. Caput, D., Beutler, B., Hartog, K., Thayer, R., Brown-Shirmen, S. and Cerami, A. (1986). Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci USA, 83, 1670.
30. Brewer, G. and Ross, J. (1988). Poly (A) shortening and degradation of the 3′ A + U-rich sequences of human c-myc mRNA in a cell-free system. Mol Cell Biol, 8, 1697.
31. Brewer, G. (1991). An A+U-rich element RNA-binding factor regulates c-myc mRNA stability in vitro. Mol Cell Biol, 11, 2460.
32. Cairo, M., Suen, Y., Knoppel, E., van de Ven, C., Nguyen, A. and Sender, L. (1991). Decreased stimulated GM-CSF production and GM-CSF gene expression but normal numbers of GM-CSF receptors in human term newborns compared to adults. Pediatr Res, 30(4), 362.
33. Suen, Y., Lee, S., Schreurs, J., Knoppel, E. and Cairo, M. S. (1994). Decreased macrophage colony-stimulating factor mRNA expression from activated cord versus adult mononuclear cells: altered post transcriptional stability. Blood, 84, 4269.
34. Wong, G., Witek, J. S., Temple, P. A., Wilkkens, K. M., Leary, A. C., Luxemburg, D. P., Jones, S. S., Brown, E. L., Kay, R. M., Orr, E. C., Shoemaker, C., Golde, D. W., Kaufman, R. J., Hewick, R. M., Want, E. A. and Clark, S. C. (1985). Human GM-CSF: Molecular cloning of the complementary DNA and purification of the natural and recombinant proteins. Science, 228, 810.
35. Wong, G.,Temple, P., Leary, A., Witek-Gianotti, J., Yang, Y., Ciarletta, A., Chung, M., Murtha, P., Kriz, R. and Kaufman, R. (1987). Human CSF-I: Molecular cloning and expression of 4kb cDNA encoding the human urinary protein. Science, 235, 1504.
36. Buzby, J. S., Lee, S. M., DeMaria, C. T., Brewer, G., Van Winkle, P. and Cairo, M. S. (1996). Increased granulocyte-macrophage colony-stimulating factor mRNA instability in cord versus adult mononuclear cells is translation-dependent and associated with increased levels of A+U-rich element binding factor. Blood, 88, 2889.
37. Jochum, C., Voth, R., Rossol, S., Buschenfelde, K., Hess, G., Will, H., Schroder, H., Steffen, R. and Muller, W. (1990). Immunosuppressive function of hepatitis B antigens in vitro: Role of endoribonuclease V as one potential trans inactivator for cytokines in macrophages and human hepatoma cells. Journal of Virology, 64(4), 1956.
38. Malter, J. (1989). Identification of an AUUUA-specific messenger RNA binding protein. Science, 246, 664.
39. Vakalopoulou, E., Schaack, J. and Shenk, T. (1991). A 32-kilodalton protein binds to AU-rich domains in the 3′ untranslated regions of rapidly degraded mRNAs. Mol Cell Biol, 11, 3355.
40. Bohjanen, P., Petryniak, B., June, C., Thompson, C. and Lindsten, T. (1992). AU RNA-binding factors differ in their binding specificities and affinities. The Journal of Biological Chemistry, 267(9), 6302.
41. Hamilton, B., Nagy, E., Malter, J., Arrick, B. and Rigby, W. (1993). Association of heterogeneous nuclear ribonucleoprotein A1 and C proteins with reiterated AUUUA sequences. The Journal of Biological Chemistry, 268(12), 8881.
42. Levine, T., Gao, F., King, P., Andrews, L. and Keene, J. (1993). Hel-N1: an autoimmune RNA-binding protein with specficity for 3′ uridylate-rich untranslated regions of growth factor mRNAs. Molecular and Cellular Biology, 13(6), 3494.
43. Nakagawa, J., Waldner, H., Meyer-Monard, S., Hofsteenge, J., Jeno, P. and Moroni, C. (1995). AUH, a gene encoding and AU-specific RNA binding protein with intrinsic enoyl-CoA hydratase activity. Proc. Natl Acad. Sci., 92, 2051.
44. Hirayama, F., Katayama, N., Neben, S., Donaldson, D., Nickbarg, E. B., Clark, S. C. and Ogawa, M. (1993). Synergistic interaction between interleukin-12 and steel factor in support of proliferation of murine lympho-hematopoietic progenitors in culture. Blood, 83, 92.
45. Ploemacher, R., van Soest, P., Voorwinden, H. and Boudewijn, A. (1993). Interleukin-12 synergizes with Interleukin-3 and Steel factor to enhance recovery of murine hemopoietic stem cells in liquid culture. Leukemia, 7, 1381.
46. + T-lymphocytes, and NK cells. J Immunol, 149, 3495.
47. + NK cells. J Immunol, 148, 2429.
48. |48] Gately, M., Desai, B., Wolitzky, A., Quinn, P., Dwyer, C., Podlaski, F., Familletti, P., Sinigaglia, F., Chizonnite, R., Gubler, U. and Stern, A. (1991). Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J Immunol, 147, 874.
49. Mehrotra, P. T., Grant, A. J. and Siegel, J. P. (1995). Synergistic effects of IL-7 and IL-12 on human T-cell activation, J Immunol, 154, 5093.
50. Kubin, M., Kamoun, M. and Trinchieri, G. (1994). Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T-cells. J Exp Med, 180, 211.
51. Bertagnolli, M. M., Lin, B. Y., Young, D. and Herrmann, S. H. (1992). IL-12 augments antigen-dependent proliferation of activated T lymphocytes. J Immunol, 149, 3778.
52. Chan, S. H., Perussia, B., Gupta, J. W., Kobayashi, M., Pospisil, M., Young, H. A., Wolf, S. F., Young, D., Clark, S. C. and Trinchieri, G. (1991). Induction of IFN-γ production by NK cell stimulatory factor (NKSF): Characterization of the responder cells and synergy with other inducers. J Exp Med, 173, 869.
53. Aste-Amezaga, M., D'Andrea, A., Kubin, M. and Trinchieri, G. (1994). Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells. Cell Immunol, 156, 480.
54. + T-cells through IL-12 produced by listeria-induced macrophages. Science, 260, 547.
55. + T-cells. Immunol Rev, 123, 209.
56. Manetti, R., Parronchi, P., Giudizi, M. G., Piccinni, M., Maggi, E., Trinchieri, G. and Romagnani, S. (1993). Natural killer cell stimulatory factor (Interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med, 177, 1199.
57. Wu, C., Demeure, C., Kiniwa, M., Gately, M. and Delespesse, G. (1993). IL-12 induces the production of IFN-γ by neonatal human CD4 T-cells. J Immunol, 151, 1938.
58. + T-cells. J Immunol, 154, 9.
59. +4 cells in the human neonate. J Immunol, 145(1), 102.
60. Lewis, D. B., Prickett, K. S., Larsen, A., Grabstein, K., Weaver, M. and Wilson, C. B. (1988). Restricted production of interleukin-4 by activated human T-cells. Proc Natl Acad Sci, 85, 9743.
61. + T-cell clones. J Immunol, 143, 907.
62. Robertson, M., Soiffer, R., Wolf, S., Manley, T., Donahue, C., Young, D., Herrmann, S. and Ritz, J. (1992). Response of human natural killer cells to natural killer cell stimulatory factor: cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J Exp Med, 175, 779.
63. Trinchieri, G., Matsumoto-Kobayashi, M., Clark, S. C., Seehra, J., London, L. and Perussia, B. (1984). Response of resting human peripheral blood natural killer cells to interleukin 2. J Exp Med, 160(4), 1147.
64. Phillips, J. H. and Lanier, L. L. (1986). Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T-lymphocytes to cytolysis. J Exp Med, 164(3), 814.
65. Grimm, E., Mazumder, A., Zhang, H. and Rosenberg, S. (1982). Lymphokine-acivated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med, 155, 1823.
66. Grimm, E. A., Robb, R. J., Roth, J. A., Neckers, L. M., Lachman, L. B., Wilson, D. J. and Rosenberg, S. A. (1983). Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells. J Exp Med, 158(4), 1356.
67. DeBlaker-Hohe, D. F., Yamauchi, A., Yu, C-R., Horvath-Arcidiacono, J. A. and Bloom, E. T. (1995). IL-12 synergized with IL-2 to induce lymphokine-activated cytotoxicity and perform and granzyme gene expression in fresh human NK cells. Cell Immunol, 165, 33.
68. + T lymphocytes. J Immunol, 151, 2444.
69. Soiffer, R., Robertson, M., Murray, C., Cochran, K. and Ritz, J. (1993). Interleukin-12 augments cytolytic activity of peripheral blood lymphocytes from patients with hematologic and solid malignancies. Blood, 82, 2790.
70. Chehimi, J., Starr, S., Frank, I., Rengaraju, M., Jackson, S., Llanes, C., Kobayashi, M., Perussia, B., Young, D., Nickbarg, E., Wolf, S. and Trinchieri, G. (1992). Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J Exp Med, 175, 789.
71. Grabstein, K. H., Eisenman, J., Shanebeck, K., Rauch, C., Srinivasan, S., Fung, V., Beers, C., Richardson, J., Schoenborn, M. A., Ahdieh, M., Johnson, L., Alderson, M., Watson, J. D., Anderson, D. M. and Giri, J. G. (1994). Cloning of a T-cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science, 264, 965.
72. Burton, J. D., Bamford, R. N., Peters, C., Grant, A. J., Kurys, G., Goldman, C. K., Brennan, J., Roessler, E. and Waldmann, T. A. (1994). A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA, 91, 4935.
73. Bamford, R. N., Grant, A. J., Burton, J. C., Peters, C., Kurys, G., Goldman, C. K., Brennan, J., Roessler, E. and Waldmann, T. A. (1994), The interleukin (IL) 2 receptor β chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA, 91, 4940.
74. Qian, J. X., Lee, S. M., Suen, Y., Knoppel, E. and Cairo, M. S. (1997). Decreased IL-15 from activated cord vs adult peripheral blood mononuclear cells (MNC) and the role of IL-15 in up-regulating anti-tumor immune activity and cytokine production in cord blood. Blood (In press).
75. Ross, M. E. and Caligiuri, M. A. (1997). Cytokine-induced apoptosis of human natural killer (NK) cells identifies a novel mechanism to regulate the innate immune response. Blood, 89(3), 910.
76. -CD4 T-cells. J Clin Invest, 94, 1352.
77. Kanangat, S., Nair, S., Babu, J. S. and Rouse, B. T. (1995). Expression of cytokine mRNA in murine splenic dendritic cells and better induction of T-cell-derived cytokines by dendritic cells than by macrophages during in vitro costimulation assay using specific antigens. J Leukoc Bio, 57(2), 310.
78. + T-cells. J Immunol, 154(10), 5071.
79. Zitvogel, L., Tahara, H., Robbins, P. D., Storkus, W. J., Clarke, M. R., Nalesnik, M. A. and Lotze, M. T. (1995). Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts. J Immunol, 155, 1393.